RefBan

Referral Banners

Yashi

Tuesday, May 20, 2014

Reuters Health Report

Click to View in Browser
05/20/2014
Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between
E-cigarettes boost quitting success among smokers, study finds
LONDON(Reuters) - Smokers trying to quit are 60 percent more likely to report success if they switch to e-cigarettes than if they use nicotine products like patches or gum, or just willpower, scientists said on Tuesday.
Vaccines group seeks $7.5 billion to protect 300 million children
LONDON (Reuters) - The GAVI global vaccines alliance issued a plea on Tuesday for $7.5 billion to help immunize another 300 million children against life-threatening diseases between 2016 and 2020 and save up to 6 million more lives.
Researchers to study whether mobile phones affect teenage brains
LONDON (Reuters) - British researchers are launching the largest study in the world to investigate whether using mobile phones and other wireless gadgets might affect children's brain development.
Ophthotech may get over $1 billion from eye drug deal with Novartis
(Reuters) - Ophthotech Corp said it could potentially receive over $1 billion in payments as part of a licensing deal for its experimental eye drug with Novartis AG.
FDA approves Ajinomoto's no-calorie sweetener
(Reuters) - U.S. regulators have approved a new non-caloric sweetener from
Teva launching 3 drugs in 2014 with combined peak sales of $1 bln
TEL AVIV (Reuters) - Teva Pharmaceutical Industries is launching three new products in 2014 with combined estimated peak sales of $1 billion, the chief executive of the world's biggest generic drugmaker said on Tuesday.
Medtronic settles heart valve patent fight with Edwards
(Reuters) - Medtronic Inc agreed to pay royalties to rival Edwards Lifesciences Corp so it can continue to sell its CoreValve replacement heart valves, the medical device maker said on Tuesday.
Glaxo, Genmab say disappointed with study of lymphoma treatment
(Reuters) - GlaxoSmithKline and Danish biotech company Genmab said disappointing results from a study on treating relapsed lymphoma with their ofatumumab drug meant it was unlikely they would seek its regulatory approval.
What do you want in a spouse? Genetic similarity may help
WASHINGTON (Reuters) - He leaves the toilet seat up, prefers old Japanese monster movies to romantic comedies and fancies mixed martial arts over ballet. So what do you have in common with your husband?
Study questions role of vitamin D in asthma
NEW YORK (Reuters Health) - Giving people with asthma and low vitamin D levels extra doses of the vitamin doesn't do much to help their lungs, a new study suggests.
Related Video
Mystery fish stumps scientists
US Navy turns seawater into fuel
SUBSCRIBE TO OTHER REUTERS NEWSLETTERS
 Reuters Deals Today
The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today  
Reuters Business Today
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today  
» MORE NEWSLETTERS
- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter facebook Friend us on Facebook Forward this newsletter to a friend Forward to a friend

No comments:

Yashi

Chitika